37 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Synthesis, structural characterization, docking, lipophilicity and cytotoxicity of 1-[(1R)-1-(6-fluoro-1,3-benzothiazol-2-yl)ethyl]-3-alkyl carbamates, novel acetylcholinesterase and butyrylcholinesterase pseudo-irreversible inhibitors.
University Of Pardubice
Novel Tacrine-Benzofuran Hybrids as Potent Multitarget-Directed Ligands for the Treatment of Alzheimer's Disease: Design, Synthesis, Biological Evaluation, and X-ray Crystallography.
China Pharmaceutical University
Synthesis and structure-activity relationship study of benzofuran-based chalconoids bearing benzylpyridinium moiety as potent acetylcholinesterase inhibitors.
Alzahra University
Galantamine derivatives with indole moiety: Docking, design, synthesis and acetylcholinesterase inhibitory activity.
Medical University Of Sofia
Synthesis and cholinesterase inhibition of cativic acid derivatives.
Universidad Nacional Del Sur
Preparation, anticholinesterase activity and molecular docking of new lupane derivatives.
Universidad Nacional Del Sur
Petrosamine, a potent anticholinesterase pyridoacridine alkaloid from a Thai marine sponge Petrosia n. sp.
Mahidol University
Exploiting protein fluctuations at the active-site gorge of human cholinesterases: further optimization of the design strategy to develop extremely potent inhibitors.
Universit£
First gallamine-tacrine hybrid: design and characterization at cholinesterases and the M2 muscarinic receptor.
University Of Bonn
Interaction of cycloSal-pronucleotides with cholinesterases from different origins. A structure-activity relationship.
University Of Hamburg
Structure-based alignment and comparative molecular field analysis of acetylcholinesterase inhibitors.
University Of North Carolina
The simulated binding of (+/-)-2,3-dihydro-5,6-dimethoxy-2-[[1-(phenylmethyl)-4-piperidinyl]meth yl] -1H-inden-1-one hydrochloride (E2020) and related inhibitors to free and acylated acetylcholinesterases and corresponding structure-activity analyses.
Eisai
Rational design and synthesis of highly potent anti-acetylcholinesterase activity huperzine A derivatives.
The Chinese Academy Of Sciences
m-Alkyl, α,α,α-trifluoroacetophenones: A new class of potent transition state analog inhibitors of acetylcholinesterase
TBA
Methyl 2-(2-(4-formylphenoxy)acetamido)-2-substituted acetate derivatives: a new class of acetylcholinesterase inhibitors.
Sun Yat-Sen University
Molecular docking studies of natural cholinesterase-inhibiting steroidal alkaloids from Sarcococca saligna.
University Of Innsbruck
Synthesis, anticholinesterase activity and structure-activity relationships of m-Aminobenzoic acid derivatives.
Instituto PolitéCnico Nacional
Hydroxypyridinone-Based Iron Chelators with Broad-Ranging Biological Activities.
Zhejiang University
Propargylamine-derived multi-target directed ligands for Alzheimer's disease therapy.
Universidade De Lisboa
Synthesis and activity studies of N-[omega-N'-(adamant-1'-yl)aminoalkyl]- 2-(4'-dimethylaminophenyl)acetamides: in the search of selective inhibitors for the different molecular forms of acetylcholinesterase.
Istituto Di Strutturistica Chimica G. Giacomello
Novel tetrahydrocarbazole benzyl pyridine hybrids as potent and selective butryl cholinesterase inhibitors with neuroprotective and ?-secretase inhibition activities.
Tehran University Of Medical Sciences
Design, synthesis and biological evaluation of multifunctional tacrine-curcumin hybrids as new cholinesterase inhibitors with metal ions-chelating and neuroprotective property.
China Pharmaceutical University
Inhibition and Allosteric Regulation of Monomeric Phosphoenolpyruvate Carboxykinase by 3-Mercaptopicolinic Acid.
The University Of Kansas Medical Center
Targeted polypharmacology: discovery of dual inhibitors of tyrosine and phosphoinositide kinases.
University Of California San Francisco
Inhibitor Scaffolds for 2-Oxoglutarate-Dependent Histone Lysine Demethylases.
University Of Oxford
The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP.
Harvard Medical School
Small-molecule scaffolds for CYP51 inhibitors identified by high-throughput screening and defined by X-ray crystallography.
University Of California San Francisco
Novel inhibitors of the v-raf murine sarcoma viral oncogene homologue B1 (BRAF) based on a 2,6-disubstituted pyrazine scaffold.
Cancer Research Uk Centre For Cancer Therapeutics
Structure-activity relationship studies of phenanthridine-based Bcl-XL inhibitors.
A* Star